Cargando…
Reply to “Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?”
Autores principales: | Fedson, David S., Jacobson, Jeffrey R., Rordam, Ole Martin, Opal, Steven M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Microbiology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791843/ https://www.ncbi.nlm.nih.gov/pubmed/26908575 http://dx.doi.org/10.1128/mBio.00094-16 |
Ejemplares similares
-
Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor Blockers
por: Fedson, David S., et al.
Publicado: (2015) -
Reply to Siniorakis et al., “COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure”
por: Fedson, David S., et al.
Publicado: (2020) -
Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?
por: Wiwanitkit, Viroj
Publicado: (2016) -
Reply to “Statins may decrease the Fatality Rate of MERS Infection”
por: Totura, Allison L., et al.
Publicado: (2015) -
Authors’ Reply
por: Ravari, Hassan, et al.
Publicado: (2013)